FMC Corp vs Teradyne, Inc. — how do they compare? FMC Corp trades at $11.36 (market cap $1.36B), while Teradyne, Inc. trades at $320.57 (market cap $53.56B). The key difference: Teradyne, Inc. is far larger — about 39.4× FMC Corp's market cap, and FMC Corp pays the higher dividend (2.95%). Which is the better fit depends on your goals.
| FMC | TER | |
|---|---|---|
Market Cap | $1.36B | $53.56B |
Sector | Basic Materials | Technology |
52-Week High | $43.90 | $483.84 |
52-Week Low | $10.72 | $90.15 |
Enterprise Value | $5.50B | $53.39B |
Dividend Yield | 2.95% | 0.15% |
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.
The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.
Teradyne (TER) trades at $322.19, down 8.79% over 24 hours, reflecting recent market pressure despite strong earnings beats. The stock shows bearish technical signals with support near $308, while fundamentals reveal robust profitability with 22.55% net margins and 28.75% ROE. Recent news highlights AI-driven growth in semiconductor testing, with Q2 2026 earnings anticipated on July 28, 2026.
Outlook remains positive given analyst consensus of $453.60 price target and 64.52% buy ratings, though high valuations (P/E 63.47) and technical weakness pose near-term risks. Long-term growth is supported by expanding AI infrastructure demand, but investors should monitor competitive pressures and execution on Q2 earnings.
Trailing returns across standard periods
Latest headlines on both assets
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Read more on TER →